Surgery for malignant pleural mesothelioma: Why we need controlled trials

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 4, 2014, Pages 591-592

  Treasure, Tom ^a   Dusmet, Michael ^b   Fiorentino, Francesca ^c   Lim, Eric ^b   Waller, David ^d   Lees, Belinda ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Extrapleural pneumonectomy; Mesothelioma; Pleurectomy; Randomized controlled trials; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; EDITORIAL; GOLD STANDARD; HUMAN; LUNG RESECTION; PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THORACOTOMY; AGED; CONTROLLED STUDY; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MESOTHELIOMA; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

AGED; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MESOTHELIOMA; PNEUMONECTOMY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84896457394     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezu001     Document Type: Editorial

References (10)

1. Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763-72.
2. Chusteck J. MesoVATS: Improved Symptoms, Not Survival, in Mesothelioma:29th October 2013. http://www.medscape.com/viewarticle/813384 (accessed 10 December 2013)
3. Hiddinga BI, van Meerbeeck JP. Surgery in mesothelioma-where do we go after MARS? J Thorac Oncol 2013;8:525-9.
4. Fiorentino F, Treasure T. Pulmonary metastasectomy: are observational studies sufficient evidence for effectiveness? Ann Thorac Surg 2013;96:1129-31.
5. Treasure T, Utley M. Statistics for the rest of us: ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg 2007;133:1414-8.
6. Utley M, Fiorentino F, Treasure T. Obtaining an upper estimate of the survival benefit associated with surgery for mesothelioma. Eur J Cardiothorac Surg 2010;38:241-4.
7. Datta A, Smith R, Fiorentino F, Treasure T. Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position. Thorax 2014;69:194-7.
8. Treasure T, Utley M, O'Byrne K. MARS: a sense of perspective and an inconvenient truth. J Thorac Oncol 2013;8:e48-9.
9. Cao CQ, Yan TD, Bannon PG, McCaughan BC. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol 2010;5:1692-703.
10. Rena O, Casadio C. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure. Lung Cancer 2012;77:151-5.